Lupin Launches Formoflo-G World's First Triple MDI For COPD In India

Lupin launched Formoflo-G MDI in India after DCGI approval, calling it world's first fixed-dose triple-combination metered-dose inhaler for moderate-to-severe COPD, combining glycopyrronium, formoterol and fluticasone as twice-daily single-strength dose for India's 55m COPD patients, reinforcing its No.2 India respiratory rank.